{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:48:44Z","timestamp":1758631724930},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,4,9]],"date-time":"2011-04-09T00:00:00Z","timestamp":1302307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00213-011-2289-1","type":"journal-article","created":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T03:58:51Z","timestamp":1302235131000},"page":"315-321","source":"Crossref","is-referenced-by-count":3,"title":["Active cyamemazine metabolites in patients treated with cyamemazine (Tercian\u00ae): influence on cerebral dopamine D2 and serotonin 5-HT2A receptor occupancy as measured by positron emission tomography (PET)"],"prefix":"10.1007","volume":"217","author":[{"given":"Yann","family":"Hod\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amine","family":"Benyamina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Arbus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Reimold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,9]]},"reference":[{"key":"2289_CR1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(02)02489-5","volume":"454","author":"M Alvarez-Guerra","year":"2002","unstructured":"Alvarez-Guerra M, Hameg A, Bayle F, Dib M, Garay RP (2002) 5-HT2A receptor antagonist properties of cyamemazine in rat and guinea pig smooth muscle. Eur J Pharmacol 454:235\u2013239","journal-title":"Eur J Pharmacol"},{"key":"2289_CR2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","volume":"154","author":"T Barnes","year":"1989","unstructured":"Barnes T (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:672\u2013676","journal-title":"Br J Psychiatry"},{"issue":"2\u20133","key":"2289_CR3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2007.09.025","volume":"578","author":"A Benyamina","year":"2008","unstructured":"Benyamina A, Arbus C, Nuss P, Garay R, Neliat G, Hameg A (2008) Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes. Eur J Pharmacol 578(2\u20133):142\u2013147","journal-title":"Eur J Pharmacol"},{"key":"2289_CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1527-3458.2004.tb00023.x","volume":"10","author":"M Bourin","year":"2004","unstructured":"Bourin M, Dailly E, Hascoet M (2004) Preclinical and clinical pharmacology of cyamemazine: anxiolytic effects and prevention of alcohol and benzodiazepine withdrawal syndrome. CNS Drug Rev 10:219\u2013220","journal-title":"CNS Drug Rev"},{"key":"2289_CR5","first-page":"503","volume":"82","author":"C Gury","year":"2006","unstructured":"Gury C, Fabre C, Hameg A, Simo E, Surugue J, Garay RP, Welcomme N (2006) Prescription d\u2019antipsychotiques en milieu hospitalier sp\u00e9cialis\u00e9. Inf Psychiatr 82:503\u2013509","journal-title":"Inf Psychiatr"},{"key":"2289_CR6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0006-2952(02)01515-0","volume":"65","author":"A Hameg","year":"2003","unstructured":"Hameg A, Bayle F, Nuss P, Dupuis P, Garay RP, Dib M (2003) Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes. Biochem Pharmacol 65:435\u2013440","journal-title":"Biochem Pharmacol"},{"key":"2289_CR7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00213-005-2172-z","volume":"180","author":"Y Hode","year":"2005","unstructured":"Hode Y, Reimold M, Demazieres A, Reischl G, Bayle F, Nuss P, Hameg A, Dib M, Macher JP (2005) A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian). Psychopharmacology (Berl) 180:377\u2013384","journal-title":"Psychopharmacology (Berl)"},{"key":"2289_CR8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pnpbp.2005.08.015","volume":"30","author":"P Lemoine","year":"2006","unstructured":"Lemoine P, Kermadi I, Garcia-Acosta S, Garay RP, Dib M (2006) Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome. Prog Neuro-Psychopharmacol Biol Psychiatry 30:131\u2013137","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2289_CR9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","volume":"16","author":"J Logan","year":"1996","unstructured":"Logan J, Fowler JS, Volkow ND, Wang G-J, Ding Y-S, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834\u2013840","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Suppl","key":"2289_CR10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"212","author":"G Simpson","year":"1970","unstructured":"Simpson G, Angus J (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212(Suppl):11\u201319","journal-title":"Acta Psychiatr Scand"},{"key":"2289_CR11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00004647-200202000-00012","volume":"22","author":"J Varga","year":"2002","unstructured":"Varga J, Szabo Z (2002) Modified regression model for the Logan plot. J Cereb Blood Flow Metab 22:240\u2013244","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-011-2289-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-011-2289-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-011-2289-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:12:23Z","timestamp":1558642343000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-011-2289-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,9]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["2289"],"URL":"https:\/\/doi.org\/10.1007\/s00213-011-2289-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,9]]}}}